Effectiveness of Peripheral Intravenous Line Securement With Splint in Neonates
1 other identifier
interventional
192
1 country
1
Brief Summary
Splints are often used in neonatal intensive care units (NICUs) to immobilize the limb and stabilize the catheter, theoretically reducing complications by minimizing movement at the catheter site. Unfortunately, not much local data exist on the effectiveness of splints for peripheral intravenous line securement (PIVC). This study aimed to compare the dwell time of PIVCs with and without splints in neonates admitted to the NICU.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedFirst Submitted
Initial submission to the registry
May 9, 2026
CompletedFirst Posted
Study publicly available on registry
May 15, 2026
CompletedMay 15, 2026
May 1, 2026
6 months
May 9, 2026
May 14, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Dwell time
The dwell time of PIVCs with and without splints was compared, calculated from PIVC insertion to the completion of the therapy.
One week
Study Arms (2)
Group-A
EXPERIMENTALNeonates were supported with a splint for PIVC securement.
Group-B
ACTIVE COMPARATORNeonates were not supported with a splint for PIVC securement.
Interventions
Neonates were not supported with a splint for PIVC securement.
Eligibility Criteria
You may qualify if:
- Neonates
- Any gender
- Admitted to the NICU and required PIVC insertion
You may not qualify if:
- Skin conditions like fragile skin syndromes, dermatitis, or local infections that may worsen with splint and adhesive use
- Congenital limb deformities like clubfoot, polydactyly, joint contractures that impede proper splint application
- Severe limb edema
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr. Ruth KM Pfau Civil Hospital/Dow University of Health Sciences
Karachi, Sindh, 74200, Pakistan
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zainab Khalid
Dr. Ruth KM Pfau Civil Hospital/Karachi, Dow University of Health Sciences, Karachi
- STUDY DIRECTOR
Muhammad Rafique, FCPS
Dr. Ruth KM Pfau Civil Hospital, Karachi/Dow University of Health Sciences, Karachi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Research Consultant
Study Record Dates
First Submitted
May 9, 2026
First Posted
May 15, 2026
Study Start
October 1, 2025
Primary Completion
March 31, 2026
Study Completion
March 31, 2026
Last Updated
May 15, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Data can be shared on a reasonable request.